What does CUSIP 13739U104 represent in this 13F holders report?

CUSIP 13739U104 is the security identifier for CGIX - CANCER GENETICS INC - COM used to aggregate holder disclosures.

How many institutions held CGIX - CANCER GENETICS INC - COM in Q4 2019?

1 institutional investor reported CGIX - CANCER GENETICS INC - COM for Q4 2019. Use the holders table for investor-level position and value details.

CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Equity / COM
Total 13F shares: 444
Share change: -4,673,367
Total reported value: $3,000
Price per share: $6.76
Number of holders: 1
Value change: -$482,000
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 13739U104:

Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q4 2019

As of 31 Dec 2019, CANCER GENETICS INC - COM (CGIX) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 444 shares. The largest 1 holders included Mayo Clinic. This page lists 1 institutional shareholders reporting positions in this security for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.